Detection rates and false positive rates for Down's syndrome screening: how precisely can they be estimated and what factors influence their value?

Abstract:

:Down's syndrome screening is currently carried out using a combination of biochemical markers measured in maternal serum samples; these include MSAFP, Total hCG, uE3 and Free beta-hCG. Recently a number of papers have compared the effectiveness of different combinations of these markers. Some recommend MSAFP, Total hCG and uE3 (triple test) while others advocate MSAFP and Free beta-hCG (double test). The cases put forward to support these tests rely on estimated detection and false positive rates for the proposed test. A recent paper by Wright used simulation techniques to estimate the effects of sampling error on such error rates. In prospective studies there are two methods commonly used for estimating these rates. We obtain formulae for the standard deviations of these estimates and show that one of them always gives a smaller standard error than the other. We also show that in such studies the accuracy of estimating detection rates and false positive rates depends not only upon the method of calculation but also on the age distribution of pregnant women and the parameters used to calculate patient specific risk. We show that these effects can result in estimation errors of such magnitude that many observed differences in detection rates could be of questionable significance, a conclusion also reached by Wright.

journal_name

Stat Med

journal_title

Statistics in medicine

authors

Dunstan FD,Gray JC,Nix AB,Reynolds T

doi

10.1002/(sici)1097-0258(19970715)16:13<1481::aid-s

subject

Has Abstract

pub_date

1997-07-15 00:00:00

pages

1481-95

issue

13

eissn

0277-6715

issn

1097-0258

pii

10.1002/(SICI)1097-0258(19970715)16:13<1481::AID-S

journal_volume

16

pub_type

杂志文章
  • Multilevel mixed effects parametric survival models using adaptive Gauss-Hermite quadrature with application to recurrent events and individual participant data meta-analysis.

    abstract::Multilevel mixed effects survival models are used in the analysis of clustered survival data, such as repeated events, multicenter clinical trials, and individual participant data (IPD) meta-analyses, to investigate heterogeneity in baseline risk and covariate effects. In this paper, we extend parametric frailty model...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.6191

    authors: Crowther MJ,Look MP,Riley RD

    更新日期:2014-09-28 00:00:00

  • Logistic regression with incompletely observed categorical covariates--investigating the sensitivity against violation of the missing at random assumption.

    abstract::Missing values in the covariates are a widespread complication in the statistical inference of regression models. The maximum likelihood principle requires specification of the distribution of the covariates, at least in part. For categorical covariates, log-linear models can be used. Additionally, the missing at rand...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780141205

    authors: Vach W,Blettner M

    更新日期:1995-06-30 00:00:00

  • On design considerations and randomization-based inference for community intervention trials.

    abstract::This paper discusses design considerations and the role of randomization-based inference in randomized community intervention trials. We stress that longitudinal follow-up of cohorts within communities often yields useful information on the effects of intervention on individuals, whereas cross-sectional surveys can us...

    journal_title:Statistics in medicine

    pub_type: 杂志文章,评审

    doi:10.1002/(SICI)1097-0258(19960615)15:11<1069::AID-S

    authors: Gail MH,Mark SD,Carroll RJ,Green SB,Pee D

    更新日期:1996-06-15 00:00:00

  • Comparison of trends in HIV infection for two risk categories.

    abstract::Sensible plans for health-care needs and determination of priorities for expenditure require regular assessment of trends in HIV incidences. In particular, trends in the relative HIV incidences of different risk categories are useful when assessing whether current control strategies are working equally well for all ri...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/(SICI)1097-0258(19960830)15:16<1779::AID-S

    authors: Becker NG,Cui JS

    更新日期:1996-08-30 00:00:00

  • A comparison of three approaches to estimate exposure-specific incidence rates from population-based case-control data.

    abstract::In population-based case-control studies, an attempt is made to identify all incident cases diagnosed in a specified population during a fixed time interval. Assuming that this goal is met allows one to obtain measures of risk other than relative risks. In this paper, we describe three approaches to estimate exposure-...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780130526

    authors: Benichou J,Wacholder S

    更新日期:1994-03-15 00:00:00

  • Analyzing longitudinal data with patients in different disease states during follow-up and death as final state.

    abstract::This paper considers the analysis of longitudinal data complicated by the fact that during follow-up patients can be in different disease states, such as remission, relapse or death. If both the response of interest (for example, quality of life (QOL)) and the amount of missing data depend on this disease state, ignor...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3755

    authors: le Cessie S,de Vries EG,Buijs C,Post WJ

    更新日期:2009-12-30 00:00:00

  • Modelling the geographical distribution of co-infection risk from single-disease surveys.

    abstract:BACKGROUND:The need to deliver interventions targeting multiple diseases in a cost-effective manner calls for integrated disease control efforts. Consequently, maps are required that show where the risk of co-infection is particularly high. Co-infection risk is preferably estimated via Bayesian geostatistical multinomi...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4243

    authors: Schur N,Gosoniu L,Raso G,Utzinger J,Vounatsou P

    更新日期:2011-06-30 00:00:00

  • Comparison of adjusted attributable risk estimators.

    abstract::The estimation of attributable risk in the presence of confounding and effect modification is studied in this paper. Different adjustment methods for the attributable risk are reviewed. The results of a stimulation study comparing these methods under the unrestricted multinomial sampling model are reported. From the s...

    journal_title:Statistics in medicine

    pub_type: 杂志文章,评审

    doi:10.1002/sim.4780111606

    authors: Gefeller O

    更新日期:1992-12-01 00:00:00

  • Alpha calculus in clinical trials: considerations and commentary for the new millennium.

    abstract::Regardless of whether a statistician believes in letting a data set speak for itself through nominal p-values or believes in strict alpha conservation, the interpretation of experiments which are negative for the primary endpoint but positive for secondary endpoints is the source of some angst. The purpose of this pap...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0258(20000330)19:6<767::aid-sim

    authors: Moyé LA

    更新日期:2000-03-30 00:00:00

  • Baseline risk as predictor of treatment benefit: three clinical meta-re-analyses.

    abstract::A relationship between baseline risk and treatment effect is increasingly investigated as a possible explanation of between-study heterogeneity in clinical trial meta-analysis. An approach that is still often applied in the medical literature is to plot the estimated treatment effects against the estimated measures of...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/1097-0258(20001230)19:24<3497::aid-sim830>

    authors: Arends LR,Hoes AW,Lubsen J,Grobbee DE,Stijnen T

    更新日期:2000-12-30 00:00:00

  • Survival time models for analysing drug combination treatments.

    abstract::Several relative risk models for survival time data in drug combination therapy are derived and their properties are discussed. The main intention of this paper is to clarify the differences among the models in order to help to choose the appropriate one in a given situation. The models are motivated by discussing the...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780091216

    authors: Kübler J,Schumacher M

    更新日期:1990-12-01 00:00:00

  • Application of kriging models for a drug combination experiment on lung cancer.

    abstract::Combinatorial drugs have been widely applied in disease treatment, especially chemotherapy for cancer, due to its improved efficacy and reduced toxicity compared with individual drugs. The study of combinatorial drugs requires efficient experimental designs and proper follow-up statistical modeling techniques. Linear ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.7971

    authors: Xiao Q,Wang L,Xu H

    更新日期:2019-01-30 00:00:00

  • Bayesian non-response models for categorical data from small areas: an application to BMD and age.

    abstract::We provide a Bayesian analysis of data categorized into two levels of age (younger than 50 years, at least 50 years) and three levels of bone mineral density (normal, osteopenia, osteoporosis) for white females at least 20 years old in the third National Health and Nutrition Examination Survey. For the sample, the age...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.1985

    authors: Nandram B,Liu N,Choi JW,Cox L

    更新日期:2005-04-15 00:00:00

  • A geometric confidence ellipse approach to the estimation of the ratio of two variables.

    abstract::One is often interested in the ratio of two variables, for example in genetics, assessing drug effectiveness, and in health economics. In this paper, we derive an explicit geometric solution to the general problem of identifying the two tangents from an arbitrary external point to an ellipse. This solution permits num...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3398

    authors: Walter SD,Gafni A,Birch S

    更新日期:2008-12-10 00:00:00

  • Stochastic approximation EM for large-scale exploratory IRT factor analysis.

    abstract::A stochastic approximation EM algorithm (SAEM) is described for exploratory factor analysis of dichotomous or ordinal variables. The factor structure is obtained from sufficient statistics that are updated during iterations with the Robbins-Monro procedure. Two large-scale simulations are reported that compare accurac...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.8217

    authors: Camilli G,Geis E

    更新日期:2019-09-20 00:00:00

  • Accounting for competing risks in randomized controlled trials: a review and recommendations for improvement.

    abstract::In studies with survival or time-to-event outcomes, a competing risk is an event whose occurrence precludes the occurrence of the primary event of interest. Specialized statistical methods must be used to analyze survival data in the presence of competing risks. We conducted a review of randomized controlled trials wi...

    journal_title:Statistics in medicine

    pub_type: 杂志文章,评审

    doi:10.1002/sim.7215

    authors: Austin PC,Fine JP

    更新日期:2017-04-15 00:00:00

  • Modelling heterogeneity in clustered count data with extra zeros using compound Poisson random effect.

    abstract::In medical and health studies, heterogeneities in clustered count data have been traditionally modeled by positive random effects in Poisson mixed models; however, excessive zeros often occur in clustered medical and health count data. In this paper, we consider a three-level random effects zero-inflated Poisson model...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3619

    authors: Ma R,Hasan MT,Sneddon G

    更新日期:2009-08-15 00:00:00

  • Chronic disease prevention: public health potential and research needs.

    abstract::This paper, arising out of an event to honour the statistical and scientific contributions of Professor Peter Armitage, is concerned with research strategies and needs for chronic disease prevention. A few highlights from recent intervention trials for the prevention of cancer, cardiovascular disease, fractures and di...

    journal_title:Statistics in medicine

    pub_type:

    doi:10.1002/sim.2045

    authors: Prentice RL

    更新日期:2004-11-30 00:00:00

  • A simple test for synergy for a small number of combinations.

    abstract::A method for detecting deviations from the Loewe additive drug combination reference model for in vitro drug combination experimentation is described. It is often difficult to fit a response surface model to drug combination data, especially in situations where the experimental design contains a sparse set of combinat...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.5905

    authors: Novick SJ

    更新日期:2013-12-20 00:00:00

  • Clinical trials: some reflections.

    abstract::The principles and historical development of clinical trials are outlined briefly. Some issues that extend the basic philosophy first put forward by Sir Austin Bradford Hill 40 years ago and that will need consideration in the future application of clinical trials are discussed. ...

    journal_title:Statistics in medicine

    pub_type: 传,历史文章,杂志文章

    doi:10.1002/sim.4780010414

    authors: Holland WW,Breeze E,Swan AV

    更新日期:1982-10-01 00:00:00

  • Sampling-based estimation for massive survival data with additive hazards model.

    abstract::For massive survival data, we propose a subsampling algorithm to efficiently approximate the estimates of regression parameters in the additive hazards model. We establish consistency and asymptotic normality of the subsample-based estimator given the full data. The optimal subsampling probabilities are obtained via m...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.8783

    authors: Zuo L,Zhang H,Wang H,Liu L

    更新日期:2021-01-30 00:00:00

  • Estimates of disease incidence in women based on antenatal or neonatal seroprevalence data: HIV in New York City.

    abstract::Piecewise constant incidence models were developed to estimate the force of infection in women from age- and time-specific antenatal or neonatal seroprevalence data. Differential inclusion of infected women in sero-surveys compared to uninfected women was taken into account, with respect to both changes in inclusion r...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780131809

    authors: Ades AE,Medley GF

    更新日期:1994-09-30 00:00:00

  • Marginal versus conditional versus 'structural source' models: a rationale for an alternative to log-linear methods for capture-recapture estimates.

    abstract::Log-linear models for capture-recapture type data are widely used for estimating sizes of populations. Log-linear methods model conditional interactions between the sources. Often, however, the marginal associations are more appropriate and easier for the practitioner to conceptualize. Analyses here of previously publ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0258(19980115)17:1<69::aid-sim7

    authors: Regal RR,Hook EB

    更新日期:1998-01-15 00:00:00

  • Comparisons of the performance of different statistical tests for time-to-event analysis with confounding factors: practical illustrations in kidney transplantation.

    abstract::Confounding factors are commonly encountered in observational studies. Several confounder-adjusted tests to compare survival between differently exposed subjects were proposed. However, only few studies have compared their performances regarding type I error rates, and no study exists evaluating their type II error ra...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.6777

    authors: Le Borgne F,Giraudeau B,Querard AH,Giral M,Foucher Y

    更新日期:2016-03-30 00:00:00

  • Multiplicity adjustment for multiple endpoints in clinical trials with multiple doses of an active treatment.

    abstract::Frequently, multiple doses of an active treatment and multiple endpoints are simultaneously considered in the designs of clinical trials. For these trials, traditional multiplicity adjustment procedures such as Bonferroni, Hochberg and Hommel procedures can be applied when treating the comparisons of different doses t...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.2101

    authors: Quan H,Luo X,Capizzi T

    更新日期:2005-07-30 00:00:00

  • Parameterization of treatment effects for meta-analysis in multi-state Markov models.

    abstract::Standard approaches to analysis of randomized controlled trials (RCTs) using Markov models make it difficult to generalize treatment effects to new patient groups and synthesize evidence across trials. This paper demonstrates how pair-wise and mixed treatment comparison meta-analysis can be applied to event history da...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4059

    authors: Price MJ,Welton NJ,Ades AE

    更新日期:2011-01-30 00:00:00

  • Re-evaluating design specifications of longitudinal clinical trials without unblinding when the key response is rate of change.

    abstract::The design of clinical trials often requires knowledge of quantities such as between- and within subject variances about which only imprecise information exists. To provide assurance that the study has the desired power to detect a minimum clinically meaningful difference between treatment groups. Gould, Gould and Shi...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780142007

    authors: Shih WJ,Gould AL

    更新日期:1995-10-30 00:00:00

  • Sample sizes for constructing confidence intervals and testing hypotheses.

    abstract::Although estimation and confidence intervals have become popular alternatives to hypothesis testing and p-values, statisticians usually determine sample sizes for randomized clinical trials by controlling the power of a statistical test at an appropriate alternative, even those statisticians who recommend the use of c...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780080705

    authors: Bristol DR

    更新日期:1989-07-01 00:00:00

  • The power of focused tests to detect disease clustering.

    abstract::Statistical tests have been proposed for determining whether incident cases of adverse health effects are 'clustered' together. Several procedures, termed 'focused', specifically analyse disease surveillance data around pre-specified putative sources of environmental hazard. Little has been done to compare the perform...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780142103

    authors: Waller LA,Lawson AB

    更新日期:1995-11-15 00:00:00

  • Analyzing longitudinal data to characterize the accuracy of markers used to select treatment.

    abstract::With the increasing availability of detailed clinical information, there is optimism that treatment choices can be selectively directed to those individuals most likely to benefit. While standard clinical trials can establish whether a treatment appears to be effective on average, subsequent work is needed to determin...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.6138

    authors: Sitlani CM,Heagerty PJ

    更新日期:2014-07-30 00:00:00